newsfilter
← Latest News
GlobeNewswire·

AVEO Oncology Announces Participation at the H.C. Wainwright Global Investment Conference

BOSTON, May 18, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (NASDAQ:AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that members of its senior management team will participate in a fireside chat at the H.C. Wainwright